BioRecilGent (B)

The case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.
Collection: IESE (España)
Ref: AD-381-E
Format: PDF
Number of pages: 1
Publication Date: Apr 4, 2022
Language: English, Spanish, Portuguese Portugal

What material is included in this case:

Other supplements

Description

The case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.
Read more
Geographic Setting: Spain
Industry Setting: Health

Learning Objective

The case can be used to introduce students to decision trees and financing methods for a newly launched company.

BioRecilGent (B)

Options of use
Number of copies
- +
As low as €6.21

Are you interested in this product?

Add it to your favourites so that your institution can purchase it.
You'll be able to order once your profile has been validated.
Add to wishlist

Leave your rating

"BioRecilGent (B)"